4//SEC Filing
ANGIODYNAMICS INC 4
Accession 0001140361-15-028638
$ANGOCIK 0001275187operating
Filed
Jul 23, 8:00 PM ET
Accepted
Jul 24, 9:30 PM ET
Size
9.8 KB
Accession
0001140361-15-028638
Insider Transaction Report
Form 4
Richard Stark
SVP, GM - Oncology
Transactions
- Award
Common Stock
2015-07-22+4,287→ 32,988 total - Award
Non-Qualified Stock Option (right to buy)
2015-07-22+14,704→ 14,704 totalExercise: $15.95From: 2016-07-22Exp: 2022-07-22→ Common Stock (14,704 underlying) - Award
Performance Right
2015-07-22+5,716→ 5,716 total→ Common Stock (5,716 underlying)
Footnotes (3)
- [F1]This acquisition of 4,287 shares of common stock ("Common Stock") of AngioDynamics, Inc. (the "Company"), represents 4,287 restricted stock units, each of which represents a contingent right to receive one share of Common Stock. These restricted stock units vest in four equal annual installments beginning on July 22, 2016, such that 25% of the restricted stock units will vest on each of July 22, 2016, 2017, 2018 and 2019.
- [F2]These stock options vest in four equal annual installments beginning on July 22, 2016, such that 25% of the options will vest on each of July 22, 2016, 2017, 2018 and 2019.
- [F3]Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period covering the Company's fiscal years 2016, 2017 and 2018. Any shares that do not vest at the end of the performance period will be forfeited.
Documents
Issuer
ANGIODYNAMICS INC
CIK 0001275187
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001275187
Filing Metadata
- Form type
- 4
- Filed
- Jul 23, 8:00 PM ET
- Accepted
- Jul 24, 9:30 PM ET
- Size
- 9.8 KB